Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: Correlation to disease activity

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 639-643

  Mielnik, Pawel ^a   Chwalinska Sadowska, Hanna ^a   Wiesik Szewczyk, Ewa ^a   Maslinski, Wlodzimierz ^a   Olesinska, Marzena ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Dermatomyositis; Disease activity; Interleukin 15; Polymyositis

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY; BLOOD; INTERSTITIAL LUNG DISEASE; MIDDLE AGED; SKIN DISEASE;

ADULT; BIOLOGICAL MARKERS; DERMATOMYOSITIS; FEMALE; HUMANS; INTERLEUKIN-15; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SKIN DISEASES;

EID: 84863319981     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1692-y     Document Type: Article

References (18)

1. Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97:14-32 (Pubitemid 32061238)
2. Sugiura T, Harigai M, Kawaguchi Y, Takagi K, Fukasawa C, Ohsako-Higami S et al (2002) N.Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int Immunol 14:917-924
3. Suzuki J, Morimoto S, Amano H, Tokano Y, Takasaki Y, Hashimoto H (2001) Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 28:2389-2391 (Pubitemid 33031965)
4. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19:101-105 (Pubitemid 30189841)
5. Chrobak L, Podzimek K, Pliskova L, Kerekes Z, Zak P, Voglova J et al (1996) Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia. Neoplasma 43:321-325 (Pubitemid 26387202)
6. Samsonov MY, Nassonov EL, Tilz GP, Geht BM, Demel U, Gurkina GT et al (1997) Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis. Br J Rheumatol 36:656-660
7. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347
8. Kurowska M, Rudnicka W, Kontny E, Janicka I, Chorazy M, Kowalczewski J et al (2002) Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 169:1760-1767 (Pubitemid 34857635)
9. Liew FY, McInnes IB (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61(S2):100-102
10. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J et al (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52:2686-2692 (Pubitemid 41369096)
11. Horak P, Hermanova Z, Ordeltova M, Faltynek L, Kusa L, Budikova M et al (2004) Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes. Vnitr Lek 50:422-427 (Pubitemid 38828509)
12. Franczuk A, Szepietowski JC, Noworolska A (2004) Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease. Acta Dermatovenerol Croat 12:71-76 (Pubitemid 38788770)
13. Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M et al (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 40:1398-1404
14. Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Clin Rheumatol 19:352-359
15. Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S et al (2006) Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma. Eur J Haematol 77:217-225 (Pubitemid 44181384)
16. Viac J, Vincent C, Palacio S, Schmitt D, Claudy A (1996) Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels. Eur J Cancer 32A:447-449
17. Holzer G, Pfandlsteiner T, Blahovec H, Trieb K, Kotz R (2003) Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumors. Anticancer Res 23:3057-3059 (Pubitemid 36969860)
18. Tesarova P, Kvasnicka J, Umlaufova A, Homolkova H, Jirsa M, Tesar V (2000) Soluble TNF and IL-2 receptors in patients with breast cancer. Med Sci Monit 6:661-667